Skip to main content

Advertisement

Log in

Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Hallux valgus surgery (HVS) is one of the most common orthopedic procedures, often occurring in older adults. Guidelines provide inconsistent recommendations about venous thromboembolism (VTE) prophylaxis after HVS and data are scarce regarding VTE presentation and outcomes in this population. We reported the clinical characteristics and outcomes of VTE following HVS among patients enrolled in Registro Informatizado Enfermedad TromboEmbolica (RIETE), a prospective multicenter VTE registry. We compared the findings with those of other patients in RIETE. Consecutive patients with VTE post HVS were included in the study. Baseline characteristics, administration of VTE prophylaxis prior to diagnosis, presenting symptoms and signs, risk factors for VTE, and 90-day outcomes including recurrent VTE, major bleeding and death were determined. A total of 54 patients with VTE post HVS were identified in RIETE [median age: 64 (interquartile range 56–71) years; 85.2% female] and were compared with 74,111 VTE patients who had not undergone HVS. Among those with VTE post HVS, 63.0% had received VTE prophylaxis, in contrast to 35.6% in the rest of the RIETE cohort. Simplified Pulmonary Embolism Severity Index was zero in 66.7% of the patients with pulmonary embolism post HVS and 33.3% of other RIETE patients (P = 0.011). Compared with other VTE patients, use of estrogens was higher in HVS group (13.0% vs 5.4%, P = 0.01). All patients with VTE post HVS (100%) and most of other VTE patients (99.6%) were treated with anticoagulation, most commonly with low-molecular weight heparins. In contrast to the rest of the patients in RIETE, the absolute number of all fatal and non-fatal outcomes at 90 days was zero in the post HVS group (i.e. no deaths, no recurrence of VTE, and no major bleeding). In a large registry of patients with VTE, all patients with VTE post HVS underwent anticoagulation. These patients had much better outcomes than the rest of VTE patients, with no deaths, recurrences or major bleeding events at 90-day follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gilheany MF, Landorf KB, Robinson P (2008) Hallux valgus and hallux rigidus: a comparison of impact on health-related quality of life in patients presenting to foot surgeons in Australia. J Foot Ankle Res 1:14

    Article  Google Scholar 

  2. Mann RA, Coughlin MJ (1993) Adult hallux valgus. In: Mann RA Coughlin MJ (eds) Surgery of the foot and ankle, 6th edn. Mosby, St. Louis, pp 167–296

    Google Scholar 

  3. Harrison WD, Walker CR (2016) Controversies and trends in United Kingdom Bunion Surgery. Foot Ankle Clin 21:207–217

    Article  Google Scholar 

  4. Menz HB, Lord SR (2001) Foot pain impairs balance and functional ability in community-dwelling older people. J Am Podiatri Med Assoc 91:222–229

    Article  CAS  Google Scholar 

  5. Nix S, Smith M, Vicenzino B (2010) Prevalence of hallux valgus in the general population: a systematic review and meta-analysis. J Foot Ankle Res 3:21

    Article  Google Scholar 

  6. Torkki M, Malmivaara A, Seitsalo S, Hoikka V, Laippala P, Paavolainen P (2001) Surgery vs orthosis vs watchful waiting for hallux valgus: a randomized controlled trial. JAMA 285:2474–2480

    Article  CAS  Google Scholar 

  7. Belatti DA, Phisitkul P (2014) Economic burden of foot and ankle surgery in the US Medicare population. Foot Ankle Int 35:334–340

    Article  Google Scholar 

  8. MedicareAustralia (2018) Medicare Item Reports. https://medicarestatistics.humanservices.gov.au/statistics/do.jsp?_PROGRAM=%2Fstatistics%2Fmbs_item_standard_report&DRILL=ag&group=49821%2C49824%2C49827%2C49830%2C49833%2C49836%2C49837%2C49838%2C49839%2C49842%2C47933&VAR=services&STAT=count&RPT_FMT=by+state&PTYPE=finyear&START_DT=201707&END_DT=201806. 2017–2018

  9. Jameson SS, Augustine A, James P, Serrano-Pedraza I, Oliver K, Townshend D, Reed MR (2011) Venous thromboembolic events following foot and ankle surgery in the English National Health Service. J Bone Jt Surg Br 93:490–497

    Article  CAS  Google Scholar 

  10. Radl R, Kastner N, Aigner C, Portugaller H, Schreyer H, Windhager R (2003) Venous thrombosis after hallux valgus surgery. J Bone Jt Surg Am 85a:1204–1208

    Article  Google Scholar 

  11. Ferrao P, Saragas N, Saragas E, Jacobson B (2014) Venous thromboembolic disease in hallux surgery. Orthop Proc 96:35–35

    Google Scholar 

  12. Bikdeli B, Bikdeli B, Visvanathan R (2018) Use of prophylaxis for prevention of venous thromboembolism in patients with isolated foot or ankle surgery: a systematic review and meta-analysis. Aust J Ageing 37:24–25

    Google Scholar 

  13. Bikdeli B, Jimenez D, Hawkins M, Ortiz S, Prandoni P, Brenner B, Decousus H, Masoudi FA, Trujillo-Santos J, Krumholz HM, Monreal M, Investigators R (2018) Rationale design and methodology of the computerized registry of patients with venous thromboembolism (RIETE). Thromb Haemost 118:214–224

    Article  Google Scholar 

  14. Saro C (2007) Hallux valgus surgery: epidemiological aspects and clinical outcome. Institutionen för klinisk vetenskap/Department of Clinical Sciences, Stockholm

    Google Scholar 

  15. Wang T-F, Wong CA, Milligan PE, Thoelke MS, Woeltje KF, Gage BF (2014) Risk factors for inpatient venous thromboembolism despite thromboprophylaxis. Thromb Res 133:25–29

    Article  CAS  Google Scholar 

  16. Northup A, Wilcox S (2017) Thromboprophylaxis failure in the adult medical inpatient. Am J Med Sci 354:107–116

    Article  Google Scholar 

  17. Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ (2015) Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients. Crit Care Med 43:401–410

    Article  CAS  Google Scholar 

  18. Graham WC, Flanigan DC (2014) Venous thromboembolism following arthroscopic knee surgery: a current concepts review of incidence, prophylaxis, and preoperative risk assessment. Sports Med 44:331–343

    Article  Google Scholar 

  19. Egermayer P (1999) Mortality of untreated deep vein thrombosis following knee arthroscopy. Chest 115:604

    Article  CAS  Google Scholar 

  20. Kelly J, Rudd A, Lewis R, Hunt B (2001) Screening for subclinical deep-vein thrombosis. QJM 94:511–519

    Article  CAS  Google Scholar 

  21. Robert-Ebadi H, Righini M (2010) Anticoagulation in the elderly. Pharmaceuticals 3:3543–3569

    Article  CAS  Google Scholar 

  22. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ (2006) Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151:713–719

    Article  Google Scholar 

  23. Ruiz-Gimenez N, Suarez C, Gonzalez R, Nieto JA, Todoli JA, Samperiz AL, Monreal M (2008) Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism—findings from the RIETE Registry. Thromb Haemost 100:26–31

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We express our gratitude to Sanofi Spain for supporting this Registry with an unrestricted educational grant. We also express our gratitude to Bayer Pharma AG for supporting this Registry. Bayer Pharma AG’s support was limited to the part of RIETE outside Spain, which accounts for a 25.28% of the total patients included in the RIETE Registry. We also thank the RIETE Registry Coordinating Center, S&H Medical Science Service, for their quality control data, logistic and administrative support and Prof.

Funding

RIETE registry is supported by research grants from Sanofi Spain and Bayer Pharma AG. The funders have no access to the database nor had any role in the design of the current study. They did not have access to the prepared manuscript, and did not have a role in the decision to submit the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bavand Bikdeli.

Ethics declarations

Conflict of interest

Dr. Behnood Bikdeli was supported by the National Heart, Lung, and. Blood Institute, National Institutes of Health, through Grant Number T32 HL007854. The content is the responsibility of the authors and does not necessarily represent the views of the NIH. Dr. Bikdeli reports that he has been a consulting expert (on behalf of the plaintiff) for litigation related to a specific type of IVC filters. Dr Ido Weinberg is on the scientific advisory board for Novate Medical and a non-compensated advisor for BTG. The current study is the idea of the investigators and has not been prepared at the request of a third party. Other authors have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Coordinator of the RIETE Registry: Manuel Monreal.

RIETE Steering Committee Members: Paolo Prandoni, Benjamin Brenner and Dominique Farge-Bancel.

RIETE National Coordinators: Raquel Barba (Spain), Pierpaolo Di Micco (Italy), Laurent Bertoletti (France), Sebastian Schellong (Germany), Inna Tzoran (Israel), Abilio Reis (Portugal), Marijan Bosevski (R. Macedonia), Henri Bounameaux (Switzerland), Radovan Malý (Czech Republic), Peter Verhamme (Belgium), Joseph A. Caprini (USA), Hanh My Bui (Vietnam).

RIETE Registry Coordinating Center: S & H Medical Science Service. Members of the RIETE Group.

SPAIN: Adarraga MD, Agud M, Aibar MA, Amado C, Arcelus JI, Ballaz A, Barba R, Barbagelata C, Barrón M, Barrón-Andrés B, Blanco-Molina A, Camon AM, Cañas I, Carrasco C, Castro J, de Ancos C, del Toro J, Demelo P, Díaz-Pedroche C, Díaz-Peromingo JA, Encabo M, Falgá C, Farfán AI, Fernández de Roitegui K, Fernández-Capitán C, Fernández-Criado MC, Fidalgo MA, Flores K, Font C, Font L, Furest I, Galián JD, García MA, García-Bragado F, García-Morillo M, García-Raso A, Gavín O, Gayol MC, Gil-Díaz A, Gómez V, Gómez-Cuervo C, González-Martínez J, Grau E, Gutiérrez J, Hernández-Blasco LM, Hermosa-Los Arcos MJ, Iglesias M, Jara-Palomares L, Jaras MJ, Jiménez D, Jiménez R, Joya MD, Jou I, Lima J, Llamas P, Lobo JL, López-Jiménez L, López-Miguel P, López-Núñez JJ, López-Reyes R, López-Sáez JB, Lorente MA, Lorenzo A, Loring M, Lumbierres M, Madridano O, Maestre A, Marchena PJ, Martín del Pozo M, Martínez-García MA, Mella C, Mellado M, Monreal M, Morales MV, Nieto ML, Nieto JA, Núñez MJ, Olivares MC, Otalora S, Otero R, Panadero-Macía M, Pedrajas JM, Pellejero G, Pérez-Ductor C, Pérez-Jacoiste A, Pérez-Rus G, Peris ML, Porras JA, Rivas A, Rodríguez-Cobo A, Rodríguez-Hernández A, Rubio CM, Ruiz-Ruiz J, Ruiz-Sada P, Sahuquillo JC, Sala-Sainz MC, Salazar V, Salgueiro G, Sampériz A, Sánchez-Muñoz-Torrero JF, Sancho T, Soler S, Suriñach JM, Tolosa C, Torres MI, Uresandi F, Valle R, Vela JR, Vidal G, Villares P, ARGENTINA: Gutiérrez P, Vázquez FJ, Vilaseca A, BELGIUM: Vanassche T, Vandenbriele C, Verhamme P, BRAZIL: Yoo HHB, CZECH REPUBLIC: Hirmerova J, Malý R, ECUADOR: Salgado E, FRANCE: Benzidia I, Bertoletti L, Bura-Riviere A, Debourdeau P, Farge-Bancel D, Helfer H, Hij A, Mahé I, Moustafa F, GERMANY: Schellong S, ISRAEL: Braester A, Brenner B, Tzoran I, IRAN: Sharif-Kashani B, ITALY: Barillari G, Bilora F, Bortoluzzi C, Brandolin B, Ciammaichella M, Dentali F, Di Micco P, Folath M, Imbalzano E, Landolfi R, Maida R, Mastroiacovo D, Pace F, Pallotti G, Pesavento R, Prandoni P, Quintavalla R, Rocci A, Siniscalchi C, Tufano A, Visonà A, Zalunardo B, LATVIA: Gibietis V, Kigitovica D, Skride A, REPUBLIC OF MACEDONIA: Bosevski M, SWITZERLAND: Bounameaux H, Mazzolai L, USA: Bikdeli B, Caprini J, VIETNAM: Bui HM. Salvador Ortiz, Universidad Autónoma Madrid and Silvia Galindo, both Statistical Advisors in S&H Medical Science Service for the statistical analysis of the data presented in this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bikdeli, B., Visvanathan, R., Weinberg, I. et al. Clinical characteristics and outcomes of venous thromboembolic events after hallux valgus surgery: insights from the RIETE registry. J Thromb Thrombolysis 49, 651–658 (2020). https://doi.org/10.1007/s11239-019-02025-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-019-02025-2

Keywords

Navigation